drugset

drugset / Trial / NCT00585312

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

NCT00585312 ↗

Phase 3 Terminated 106 enrolled Viatris Inc.

RandomizedParallel-groupDouble-blindPrevention

Summary

To test whether celecoxib can be used to prevent colon polyp formation in children with familial adenomatous polyposis (FAP).

Timeline

Start: 2006-09
Primary completion: 2013-10
Completion: 2013-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Celecoxib	Other / unclassified	16 mg/kg	—

Indications